ImVacS - The Immunotherapeutics and Vaccine Summit

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

 

Save the Date


ImVacS brings together international vaccine leaders to discuss challenges and current breakthroughs in the world of vaccines. The four vaccine-focused meetings address innovating strategies to meet current health threats, changing technology for vaccine manufacture, top challenges faced during pre-clinical development, and progress underway for adjuvants and novel delivery systems. Altogether, ImVacS provides a snapshot of where vaccine development stands today in a collegial atmosphere that fosters information exchange, networking and establishing collaborations. We hope you will join the discussion aimed to advance vaccine science.


Vac Header

VPD FC Header

ADJ Header

CLV FC Header

 



KEYNOTE PRESENTATIONS:

David Cho, Ph.D., M.P.H., Senior Scientist for Emerging and PandemicThreat Preparedness, Office of the Director, Center for Biologics Evaluation and Research (CBER), FDA

Norman Baylor, Ph.D., Director, Office of Vaccines Research and Review (OVRR), Center forBiologics Evaluation and Research (CBER), Food and Drug Administration, FDA

Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health

George Siber, Ph.D., Director, Selecta Biosciences, and Executive Chairman, Genocea Biosciences


EVENT HIGHLIGHTS:

  • 4 Conferences, ONE Location!
  • Over 60 Presentations
  • Panel Discussions
  • Exhibit & Poster Viewing


SHORT COURSES:
Monday, August 16

Vaccines Business Opportunities
Collaborations, Mergers And Acquisitions

Single-Use Systems (Disposables) For Vaccine Manufacture



By Series:
By Region: